CNP Promotes Antiarrhythmic Effects via Phosphodiesterase 2

Ventricular arrhythmia and sudden cardiac death are the most common lethal complications after myocardial infarction. Antiarrhythmic pharmacotherapy remains a clinical challenge and novel concepts are highly desired. Here, we focus on the cardioprotective CNP (C-type natriuretic peptide) as a novel...

Descripción completa

Detalles Bibliográficos
Autores principales: Cachorro, Eleder, Günscht, Mario, Schubert, Mario, Sadek, Mirna S., Siegert, Johanna, Dutt, Fabian, Bauermeister, Carla, Quickert, Susann, Berning, Henrik, Nowakowski, Felix, Lämmle, Simon, Firneburg, Rebecca, Luo, Xiaojing, Künzel, Stephan R., Klapproth, Erik, Mirtschink, Peter, Mayr, Manuel, Dewenter, Matthias, Vettel, Christiane, Heijman, Jordi, Lorenz, Kristina, Guan, Kaomei, El-Armouche, Ali, Wagner, Michael, Kämmerer, Susanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930893/
https://www.ncbi.nlm.nih.gov/pubmed/36715019
http://dx.doi.org/10.1161/CIRCRESAHA.122.322031

Ejemplares similares

Ejemplares similares